0001140361-13-039332.txt : 20131023 0001140361-13-039332.hdr.sgml : 20131023 20131023134520 ACCESSION NUMBER: 0001140361-13-039332 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20131023 DATE AS OF CHANGE: 20131023 EFFECTIVENESS DATE: 20131023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARATANA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001509190 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383826477 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-205105 FILM NUMBER: 131165386 BUSINESS ADDRESS: STREET 1: 1901 OLATHE BOULEVARD CITY: KANSAS CITY STATE: KS ZIP: 66103 BUSINESS PHONE: 913.951.2130 MAIL ADDRESS: STREET 1: 1901 OLATHE BOULEVARD CITY: KANSAS CITY STATE: KS ZIP: 66103 D 1 primary_doc.xml X0707 D LIVE 0001509190 ARATANA THERAPEUTICS, INC. 1901 OLATHE BOULEVARD KANSAS CITY KS KANSAS 66103 913.951.2130 DELAWARE None None Corporation true 2010 Jay Lichter, Ph.D. c/o Avalon Ventures 11099 North Torrey Pines Rd., Suite 290 La Jolla CA CALIFORNIA 92037 Executive Officer Director Robert Gerber c/o Locaid 475 Sansome Street, Suite 710 San Francisco CA CALIFORNIA 94111 Director Ronald L. Meeusen, Ph.D. c/o Cultivian Ventures 122 Ashton Drive Burr Ridge IL ILLINOIS 60527 Director Craig Tooman c/o Stockbourne, LLC 147 Liberty Corner Road Far Hills NJ NEW JERSEY 07931 Director John Vander Vort c/o Charles Bank 200 Clarendon Street, 54th Floor Boston MA MASSACHUSETTS 02116 Director Steven St. Peter, M.D. c/o Aratana Therapeutics, Inc. 1901 Olathe Blvd. Kansas City KS KANSAS 66103 Executive Officer Director Linda Rhodes, V.M.D., Ph.D. c/o Aratana Therapeutics, Inc. 1901 Olathe Blvd. Kansas City KS KANSAS 66103 Executive Officer Director Louise A. Mawhinney c/o Aratana Therapeutics, Inc. 1901 Olathe Blvd. Kansas City KS KANSAS 66103 Executive Officer Ernst Heinen, D.V.M., Ph.D. c/o Aratana Therapeutics, Inc. 1901 Olathe Blvd. Kansas City KS KANSAS 66103 Executive Officer Julia A. Stephanus c/o Aratana Therapeutics, Inc. 1901 Olathe Blvd. Kansas City KS KANSAS 66103 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2013-10-15 false true true 0 29750000 29750000 0 The offering involved (i) the issuance and sale of $19,750,000 of common shares in a private placement and (ii) the issuance of $10,000,000 of common shares in connection with an acquisition. false 17 0 0 0 false ARATANA THERAPEUTICS, INC. /s/ Steven St. Peter, M.D. Steven St. Peter, M.D. President and Chief Executive Officer 2013-10-23